Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dataset of paired blood mRNA and microRNA sequencing across acute septic shock and recovery.

Scientific data·2026
Same author

Circulating miR-223-3p as an Independent Biomarker of Recurrent Thrombotic Risk After Ischemic Stroke.

Biomedicines·2025
Same author

Mycotoxin-Induced Oxidative Stress and Its Impact on Human Folliculogenesis: Examining the Link to Reproductive Health.

Toxins·2025
Same author

Hypnotizability and Visual Imagery Inside and Outside Hypnosis: A Replication and Extension.

The International journal of clinical and experimental hypnosis·2025
Same author

Enhancer-driven gene regulatory network of forebrain human development provides insights into autism.

bioRxiv : the preprint server for biology·2025
Same author

Parental Burnout: A Progressive Condition Potentially Compromising Family Well-Being-A Narrative Review.

Healthcare (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 12, 2026

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
06:33

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation

Published on: January 5, 2014

Association between hypnotizability and the catechol-O-methyltransferase (COMT) polymorphism.

Anna Szekely1, Reka Kovacs-Nagy, Eva I Bányai

  • 1Institute of Psychology, Eötvös Loránd University, Budapest, Hungary. szekely.anna@ppk.elte.hu

The International Journal of Clinical and Experimental Hypnosis
|May 29, 2010
PubMed
Summary

This study confirms a link between a specific gene variant (COMT Val(158)Met SNP) and hypnotizability. Higher hypnotizability scores were associated with the presence of the Val allele in healthy adults.

More Related Videos

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Related Experiment Videos

Last Updated: Jun 12, 2026

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
06:33

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation

Published on: January 5, 2014

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Area of Science:

  • Neuroscience
  • Behavioral Genetics
  • Psychology

Background:

  • Dopaminergic systems are implicated in hypnotizability.
  • The COMT Val(158)Met single nucleotide polymorphism (SNP) has been previously associated with hypnotizability.
  • Previous studies suggested heterozygotes (Val/Met) exhibit the highest hypnotizability.

Purpose of the Study:

  • To replicate the association between the COMT Val(158)Met SNP and hypnotizability in an independent sample.
  • To investigate the additive effect of the Val allele on hypnotizability.
  • To explore potential discrepancies with prior research and their implications.

Main Methods:

  • Recruited 127 healthy Hungarian young adults.
  • Administered the Waterloo-Stanford Group C Scale of Hypnotic Susceptibility.
  • Genotyped the COMT Val(158)Met SNP (rs4680).

Main Results:

  • A significant association (p = .016) was found between COMT genotypes and hypnotizability.
  • An additive effect of the Val allele was observed: Val/Val > Val/Met > Met/Met.
  • Hypnotizability scores were highest in Val/Val (5.9), intermediate in Val/Met (4.7), and lowest in Met/Met (4.1).

Conclusions:

  • The association between the COMT Val(158)Met SNP and hypnotizability is replicated.
  • Findings support an inverted-U-shaped relationship between prefrontal dopamine and cognitive function.
  • Mediating factors like induction method (group vs. individual) are crucial.